Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder. It is the most common type of motor neuron disease (MND). Amyotrophic lateral sclerosis is a group of rare neurological disorders that primarily involve nerve cells responsible for controlling voluntary muscle movement. Amyotrophic lateral sclerosis is also known as Lou Gehrig’s disease. The disease affects the action of motor neurons which ... Read more
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder. It is the most common type of motor neuron disease (MND). Amyotrophic lateral sclerosis is a group of rare neurological disorders that primarily involve nerve cells responsible for controlling voluntary muscle movement.
Amyotrophic lateral sclerosis (ALS) commonly known as Lou Gehrig's disease, is a progressive nervous system disease that attacks nerve cells and pathways in the spinal cord and brain. Symptoms may include weakness, muscle atrophy, difficulty speaking and swallowing among others. Current treatment options are limited and aim to manage symptoms and improve quality of life. Growing research into new therapies has led to potential disease-modifying drugs in the pipeline.
The Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive disease that weakens muscles and impacts physical function. ALS affects nerve cells in the brain and spinal cord, causing loss of muscle control. Currently, there is no cure available for ALS and the available treatment options provide modest improvement in symptoms and help extend survival. Some of the major treatments for ALS include Rilutek, Radicava, Tiglutik, and generic riluzole. However, the ... Read more
The amyotrophic lateral sclerosis (ALS) treatment market involves drugs and therapies aimed at managing motor neuron damage and symptoms of ALS disease. ALS is a rare neurodegenerative disease affecting nerve cells in the brain and spinal cord. Some key drugs in the market are Rilutek, Radicava, and Edaravone. The ALS treatment drugs work by reducing glutamate levels, inhibiting neuronal death, and targeting oxidative stress and inflammation. The growing prevalence of ALS globally along with ... Read more
